181 related articles for article (PubMed ID: 16059673)
1. Interleukin-10 and interleukin-18 promoter polymorphisms in an Italian cohort of patients with undifferentiated carcinoma of nasopharyngeal type.
Pratesi C; Bortolin MT; Bidoli E; Tedeschi R; Vaccher E; Dolcetti R; Guidoboni M; Franchin G; Barzan L; Zanussi S; Caruso C; De Paoli P
Cancer Immunol Immunother; 2006 Jan; 55(1):23-30. PubMed ID: 16059673
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-10 gene promoter polymorphisms and the risk of nasopharyngeal carcinoma.
Wei YS; Kuang XH; Zhu YH; Liang WB; Yang ZH; Tai SH; Zhao Y; Zhang L
Tissue Antigens; 2007 Jul; 70(1):12-7. PubMed ID: 17559576
[TBL] [Abstract][Full Text] [Related]
3. Association of interleukin-10 (IL10) promoter genotypes with nasopharyngeal carcinoma risk in Taiwan.
Tsai CW; Tsai MH; Shih LC; Chang WS; Lin CC; Bau DT
Anticancer Res; 2013 Aug; 33(8):3391-6. PubMed ID: 23898109
[TBL] [Abstract][Full Text] [Related]
4. Clinical value of Epstein-Barr virus DNA levels in peripheral blood samples of Italian patients with undifferentiated carcinoma of nasopharyngeal type.
Bortolin MT; Pratesi C; Dolcetti R; Bidoli E; Vaccher E; Zanussi S; Tedeschi R; De Paoli P
Cancer Lett; 2006 Feb; 233(2):247-54. PubMed ID: 15907367
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the Variability of Epstein-Barr Virus Genes in Nasopharyngeal Biopsies: Potential Predictors for Carcinoma Progression.
Banko AV; Lazarevic IB; Folic MM; Djukic VB; Cirkovic AM; Karalic DZ; Cupic MD; Jovanovic TP
PLoS One; 2016; 11(4):e0153498. PubMed ID: 27071030
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus and undifferentiated nasopharyngeal carcinoma: new immunobiological and molecular insights on a long-standing etiopathogenic association.
Dolcetti R; Menezes J
Adv Cancer Res; 2003; 87():127-57. PubMed ID: 12641275
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in host immune response associated genes and risk of nasopharyngeal carcinoma development in Portugal.
Sousa H; Mesquita L; Ribeiro J; Catarino R; Breda E; Medeiros R
Immunobiology; 2016 Feb; 221(2):145-52. PubMed ID: 26391153
[TBL] [Abstract][Full Text] [Related]
9. Genetic variants in NKG2D axis and susceptibility to Epstein-Barr virus-induced nasopharyngeal carcinoma.
Viet NH; Trung NQ; Dong LT; Trung LQ; Espinoza JL
J Cancer Res Clin Oncol; 2021 Mar; 147(3):713-723. PubMed ID: 33392659
[TBL] [Abstract][Full Text] [Related]
10. Serum antibody response to lytic and latent Epstein-Barr virus antigens in undifferentiated nasopharyngeal carcinoma patients from an area of nonendemicity.
Tedeschi R; Pin E; Martorelli D; Bidoli E; Marus A; Pratesi C; Bortolin MT; Zanussi S; Vaccher E; Dolcetti R; De Paoli P
Clin Vaccine Immunol; 2007 Apr; 14(4):435-41. PubMed ID: 17329446
[TBL] [Abstract][Full Text] [Related]
11. Single nucleotide polymorphism and haplotype association of the interleukin-8 gene with nasopharyngeal carcinoma.
Wei YS; Lan Y; Tang RG; Xu QQ; Huang Y; Nong HB; Huang WT
Clin Immunol; 2007 Dec; 125(3):309-17. PubMed ID: 17720627
[TBL] [Abstract][Full Text] [Related]
12. [In situ hybridization in undifferentiated nasopharynx carcinoma in Tunisia. Report of 3 cases].
Baizig Nehla M; Hamouda B; Asma K; Farhat BA; Abderahmen L; Omrane BH; Ahmed el M
Tunis Med; 2001 Oct; 79(10):544-7. PubMed ID: 11910697
[TBL] [Abstract][Full Text] [Related]
13. Association of IL-8 (-251)T/A polymorphism with susceptibility to and aggressiveness of nasopharyngeal carcinoma.
Ben Nasr H; Chahed K; Mestiri S; Bouaouina N; Snoussi K; Chouchane L
Hum Immunol; 2007 Sep; 68(9):761-9. PubMed ID: 17869651
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of clinical parameters and Epstein-Barr virus infection in non-endemic undifferentiated carcinoma of nasopharyngeal type: a Serbian report.
Terzic TT; Boricic MI; Pendjer IP; Ruzic Zecevic DT; Tomanovic NR; Brasanac DC; Boricic IV
Med Oncol; 2011 Dec; 28(4):1325-30. PubMed ID: 20446059
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus infection and single nucleotide polymorphisms in the promoter region of interleukin 10 gene in patients with Hodgkin lymphoma.
da Silva GN; Bacchi MM; Rainho CA; de Oliveira DE
Arch Pathol Lab Med; 2007 Nov; 131(11):1691-6. PubMed ID: 17979488
[TBL] [Abstract][Full Text] [Related]
16. [Significance of confirming Epstein-Barr virus nuclear antibody as tumor marker].
Stosić-Divjak S; Dukić V; Boricić I; Racić AJ; Divjak I; Krsmanović V
Vojnosanit Pregl; 2007 Jul; 64(7):459-62. PubMed ID: 17821920
[TBL] [Abstract][Full Text] [Related]
17. Expression of cytokine and chemokine genes in Epstein-Barr virus-associated nasopharyngeal carcinoma: comparison with Hodgkin's disease.
Beck A; Päzolt D; Grabenbauer GG; Nicholls JM; Herbst H; Young LS; Niedobitek G
J Pathol; 2001 Jun; 194(2):145-51. PubMed ID: 11400141
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-10 polymorphisms and nasopharyngeal carcinoma risk: a meta-analysis.
Yu YF; Han ZG; Guo WB; Zhang GJ; Yang JK; Wu FL; Ou QY; Li YH; Cai XY; Zhan ZN; Chen JH; Xie WL; Tang L; Liu CD
Genet Mol Res; 2015 Dec; 14(4):18945-57. PubMed ID: 26782544
[TBL] [Abstract][Full Text] [Related]
19. Association of variants in the interleukin-27 and interleukin-12 gene with nasopharyngeal carcinoma.
Wei YS; Lan Y; Luo B; Lu D; Nong HB
Mol Carcinog; 2009 Aug; 48(8):751-7. PubMed ID: 19148899
[TBL] [Abstract][Full Text] [Related]
20. Cytokine gene polymorphisms, cytokine levels and the risk of colorectal neoplasia in a screened population of Northeast Scotland.
Basavaraju U; Shebl FM; Palmer AJ; Berry S; Hold GL; El-Omar EM; Rabkin CS
Eur J Cancer Prev; 2015 Jul; 24(4):296-304. PubMed ID: 25350634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
